Searched for
AJANTA PHARMA SHARES
Vedanta Aluminium set for largecap upgrade in H2 CY26; power, oil & gas arms may turn smallcapsVedanta Aluminium is likely to be upgraded to the large-cap category in AMFI’s H2 CY26 semi-annual reshuffle, while Vedanta Power, Oil & Ga...- Sunil Singhania-backed Abakkus Flexi Cap Fund increases stake in HDFC Bank, RIL and 29 others in MaySunil Singhania-backed Abakkus Flexi Cap Fund significantly increased its holdings in HDFC Bank and Reliance Industries during May. The fun...
- Stocks in news: Emcure Pharma, Dixon Technologies, Ajanta Pharma, Godrej Properties, VedantaIndian markets experienced a volatile session, closing higher amidst mixed signals. Bulls are defending the 23,000 level in Nifty, but unce...
- Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MFA promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...
- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...
- Ahead of Market: 10 things that will decide stock market action on WednesdayDomestic equities closed marginally lower due to weakness in financial and consumer shares, despite gains in IT stocks. Analysts suggest th...
- Laurus Labs adds Rs 40,150 crore to investors' wealth in a year with 120% rally. Buy, hold or book profits?Laurus Labs has significantly boosted investor wealth, adding over Rs 40,000 crore in a year with a 120% stock rally. Driven by business im...
- Ahead of Market: 10 things that will decide stock market action on ThursdayDomestic equity benchmarks ended marginally higher after four sessions of losses, supported by gains in metal, energy and consumer stocks. ...
- Vodafone Idea and 4 other midcap stocks hit 52-week highs, rally up to 40% in a monthBenchmark indices ended marginally higher as five BSE 150 Midcap stocks touched fresh 52-week highs, reflecting strong investor sentiment a...
- Stock Radar: 50% rally in 6 months! This pharma stock gave a breakout from a bullish Flag pattern; time to buy?Ajanta Pharma Ltd's stock experienced mild consolidation in August but has since regained momentum, breaking above the Flag pattern. Expert...
- Ajanta Pharma shares jump over 13% on strong Q4 results, buyback plansAjanta Pharma shares jumped 13% to Rs 2,532 in Friday's trade on BSE after the firm's consolidated net profit increased 66% year-on-year (Y...
- Ajanta Pharma announces Rs 285 crore share buyback at 24% premiumAjanta Pharma on Thursday announced a Rs 285 crore buyback of up to 10.28 lakh shares through a tender offer at a price of Rs 2,770 — a pre...
- Ajanta Pharma announces Rs 315 crore share buyback. Details hereAjanta Pharma is a speciality pharmaceutical formulation company having branded generic business in India and emerging markets, generic bus...
- Promoter group entities to sell 4.6% stake in Ajanta Pharma via block deal ThursdayThrough the sale the entities are looking at raising close to Rs 650 crore.
- This smallcap pharma company declares 350% interim dividend; record date fixedPayment of interim dividend of Rs 7/- (350%) per equity share on the face-value of Rs 2/- per share for the Financial Year 2022-23,” said t...
- Ajanta Pharma Q2 results: Profit up 15% at Rs 196 croreRevenue from operations rose to Rs 885 crore in the second quarter as compared with Rs 716 crore in the year-ago period, Ajanta Pharma said...
- Ajanta Pharma's reasonable valuations and other factors that make it this week's stock pickAjanta Pharma beat street expectations in the second quarter of 2020-21. However, it is still valued reasonably compared to other mid cap p...
- Trending stocks: Ajanta Pharma share price jumps 5%A total of 28,668 shares changed hands on the counter till 11:05AM (IST).
- Sell Ajanta Pharma, target Rs 970: Dr CK NarayanSell Ajanta Pharma Ltd. at a price target of Rs 970.0 and a stop loss at Rs 995 from the entry point.
Load More
